DM
Deerfield Management’s Protara Therapeutics TARA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-782,670
| Closed | -$18.9M | – | 148 |
|
2020
Q4 | $18.9M | Hold |
782,670
| – | – | 0.37% | 73 |
|
2020
Q3 | $13.2M | Buy |
782,670
+350,000
| +81% | +$5.89M | 0.32% | 76 |
|
2020
Q2 | $12.7M | Hold |
432,670
| – | – | 0.37% | 70 |
|
2020
Q1 | $9.95M | Sell |
432,670
-1,596,330
| -79% | -$36.7M | 0.32% | 67 |
|
2019
Q4 | $832K | Buy |
2,029,000
+804,101
| +66% | +$330K | 0.03% | 73 |
|
2019
Q3 | $318K | Hold |
1,224,899
| – | – | 0.01% | 93 |
|
2019
Q2 | $510K | Hold |
1,224,899
| – | – | 0.02% | 95 |
|
2019
Q1 | $616K | Hold |
1,224,899
| – | – | 0.02% | 92 |
|
2018
Q4 | $2.78M | Hold |
1,224,899
| – | – | 0.11% | 81 |
|
2018
Q3 | $2.39M | Hold |
1,224,899
| – | – | 0.09% | 95 |
|
2018
Q2 | $3M | Hold |
1,224,899
| – | – | 0.11% | 104 |
|
2018
Q1 | $3.06M | Hold |
1,224,899
| – | – | 0.11% | 100 |
|
2017
Q4 | $2.33M | Hold |
1,224,899
| – | – | 0.09% | 89 |
|
2017
Q3 | $2.45M | Hold |
1,224,899
| – | – | 0.11% | 86 |
|
2017
Q2 | $1.87M | Sell |
1,224,899
-107,700
| -8% | -$164K | 0.1% | 77 |
|
2017
Q1 | $2.33M | Hold |
1,332,599
| – | – | 0.09% | 98 |
|
2016
Q4 | $2.53M | Sell |
1,332,599
-237,868
| -15% | -$452K | 0.1% | 86 |
|
2016
Q3 | $14.7M | Buy |
1,570,467
+18,436
| +1% | +$172K | 0.68% | 43 |
|
2016
Q2 | $12.5M | Buy |
1,552,031
+286,688
| +23% | +$2.3M | 0.49% | 55 |
|
2016
Q1 | $9.79M | Hold |
1,265,343
| – | – | 0.42% | 56 |
|
2015
Q4 | $19.6M | Hold |
1,265,343
| – | – | 0.8% | 42 |
|
2015
Q3 | $17.6M | Hold |
1,265,343
| – | – | 0.68% | 53 |
|
2015
Q2 | $22.6M | Hold |
1,265,343
| – | – | 0.75% | 48 |
|
2015
Q1 | $14.7M | Hold |
1,265,343
| – | – | 0.48% | 50 |
|
2014
Q4 | $13.2M | Buy |
+1,265,343
| New | +$13.2M | 0.47% | 50 |
|